Skip to main content
GA

General Astronautics

General Astronautics provides robotic manipulators that enable sub‑millimeter positioning and autonomous execution of multi‑step pharmaceutical experiments in microgravity environments. The platform integrates vision and force‑feedback sensors, modular end‑effectors, and encrypted telemetry to allow continuous, crew‑free research and real‑time data analysis for pharma companies and contract research organizations.

Updated 2 months ago

Funding

Funding not disclosed

Funding rounds are not available yet.

Founders

Founder details are not available yet.

Product

Problem

Pharmaceutical research in microgravity requires precise manipulation of sensitive compounds, but conventional equipment relies on gravity and manual operation, limiting accuracy and continuous experimentation aboard space stations.

Solution

General Astronautics delivers purpose‑engineered robotic manipulators that maintain sub‑millimeter positioning accuracy for crystallization, mixing, and transfer tasks in orbital environments. The manipulators are integrated into an autonomous lab platform that executes multi‑step experimental protocols without crew intervention, enabling 24/7 pharmaceutical R&D in microgravity. Integrated sensing and adaptive control compensate for the dynamic conditions of space, while a secure data pipeline streams experiment telemetry to ground‑based analytics for real‑time monitoring and post‑flight analysis. The system is designed for plug‑and‑play deployment on commercial space stations, reducing integration effort and operational overhead.

Target Audience

Primary customers are pharmaceutical companies and contract research organizations conducting microgravity R&D, as well as space‑station operators that provide research payload services.

Features

  • Six‑degree‑of‑freedom robotic arm with microgravity‑qualified joints and low‑backlash transmission for sub‑millimeter repeatability
  • Closed‑loop vision and force‑feedback sensors that adjust positioning in real time to compensate for microgravity dynamics
  • Modular end‑effectors tailored for pharmaceutical crystallization, liquid mixing, and sterile transfer operations
  • Autonomous workflow engine with scriptable protocols that orchestrates sample preparation, reaction, and in‑situ analysis
  • Integrated environmental sensors (temperature, humidity, radiation) feeding adaptive control algorithms to maintain experimental conditions
  • End‑to‑end encrypted telemetry link delivering raw sensor data and processed analytics to ground‑based dashboards
  • OTA software updates and remote diagnostics to minimize on‑orbit maintenance downtime
  • Standardized mechanical and data interfaces compatible with ISS and commercial station docking ports
This profile is AI-generated and may contain inaccuracies.